Truist Financial Issues Positive Forecast for Aveanna Healthcare (NASDAQ:AVAH) Stock Price

Aveanna Healthcare (NASDAQ:AVAH) had its target price hoisted by Truist Financial from $9.00 to $11.00 in a research note issued to investors on Tuesday,Benzinga reports. Truist Financial currently has a hold rating on the stock.

Other research analysts have also recently issued reports about the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a research note on Friday, March 20th. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. Barclays increased their target price on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Finally, Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective on the stock in a report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $10.78.

Aveanna Healthcare Price Performance

AVAH stock opened at $9.34 on Tuesday. Aveanna Healthcare has a 1 year low of $3.73 and a 1 year high of $10.32. The firm has a market capitalization of $2.03 billion, a P/E ratio of 7.92, a P/E/G ratio of 0.96 and a beta of 1.89. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The business’s 50-day moving average is $7.78 and its two-hundred day moving average is $7.60.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. The company had revenue of $647.91 million for the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. Aveanna Healthcare’s quarterly revenue was up 15.9% on a year-over-year basis. Analysts anticipate that Aveanna Healthcare will post 0.68 earnings per share for the current fiscal year.

Insider Transactions at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 3,000,000 shares of the company’s stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total value of $24,030,000.00. Following the sale, the insider owned 190,130 shares of the company’s stock, valued at $1,522,941.30. This represents a 94.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Patrick A. Cunningham sold 125,000 shares of the stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $7.59, for a total transaction of $948,750.00. Following the completion of the sale, the insider owned 212,755 shares in the company, valued at $1,614,810.45. This represents a 37.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 31,305,664 shares of company stock worth $215,555,910. 5.30% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after purchasing an additional 1,535,351 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Aveanna Healthcare by 17.7% during the 4th quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company’s stock worth $15,110,000 after purchasing an additional 278,429 shares during the last quarter. Nuveen LLC boosted its stake in shares of Aveanna Healthcare by 135.9% during the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after purchasing an additional 905,316 shares during the last quarter. State Street Corp grew its holdings in shares of Aveanna Healthcare by 20.9% during the fourth quarter. State Street Corp now owns 1,483,265 shares of the company’s stock worth $12,118,000 after buying an additional 256,392 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Aveanna Healthcare by 49.5% during the first quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock worth $8,593,000 after buying an additional 441,707 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.